Related Articles
JF-305, a pancreatic cancer cell line is highly sensitive to the PARP inhibitor olaparib
CD9 knockdown suppresses cell proliferation, adhesion, migration and invasion, while promoting apoptosis and the efficacy of chemotherapeutic drugs and imatinib in Ph+ ALL SUP‑B15 cells
DNA‑PKcs PARylation regulates DNA‑PK kinase activity in the DNA damage response
Combination treatment with cisplatin, paclitaxel and olaparib has synergistic and dose reduction potential in ovarian cancer cells
p21 promotes gemcitabine tolerance in A549 cells by inhibiting DNA damage and altering the cell cycle